Nicolai Haase, MD, is from Dept. of Intensive Care, Copenhagen University Hospital, Denmark. He was the coordinating investigator of the randomised, multicenter Scandinavian Starch for Severe Sepsis / Septic Shock Trial comparing hydroxyethyl starch 130/0.4 vs. Ringer’s Acetate in 800 patients.

Member of the Steering Committee of the TRISS trial – an investigator-initiated multicenter RCT of red blood cell transfusion at different trigger levels of hemoglobin in patients with septic shock.